[Skip to content]

.

Study to reduce birth defects

8 September 2010

If women take folic acid in pregnancy it can reduce the chance of their baby having neural tube defects (spina bifida or anencephaly). Could other food supplements further reduce the risk of a birth defect, particularly in those cases where folic acid is not effective?

It is known that the nutrient inositol can prevent neural tube birth defects in mice and an ongoing study aims to test whether this is also the case in people.  The PONTI Study is a controlled randomized clinical trial in pregnant women - half the women receive folic acid plus inositol and half receive folic acid plus placebo.  The intention is to see whether inositol and folic acid are more effective than folic acid alone in preventing these birth conditions.

Professor Andrew Copp, Director UCL Institute of Child Health, and leading on the research said "While all pregnant women should take folic acid it is known that some people, derive less benefit from it in reducing these defects. (This may be because of their specific genetic inheritance.)  The study could therefore add very useful public health information and advice to the existing programme."

Further information about the trial for proposed participants from ponti@ich.ucl.ac.uk

Contact information:

GOSH-ICH Press Office: 020 7239 3125
Email: Coxs@gosh.nhs.uk
For genuine and urgent out of hours call speak to switchboard on 020 7405 9200

Notes to editors

Great Ormond Street Hospital for Children NHS Trust is the country’s leading centre for treating sick children, with the widest range of specialists under one roof.

With the UCL Institute of Child Health, we are the largest centre for paediatric research outside the US and play a key role in training children’s health specialists for the future.

Our charity needs to raise £50 million every year to help rebuild and refurbish Great Ormond Street Hospital, buy vital equipment and fund pioneering research. With your help we provide world class care to our very ill children and their families.